Quantum量子訊息有限公司
← 最新全球產業報告

Antibodies Contract Manufacturing Market

研究執行與發布：Grand View Research　·　發布日期 2026-07-23　·　120 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

出版商 Grand View Research產業別 Medical Devices出版日期 2026-07-23頁數 120報告編號 GVR-4-68039-920-3

授權報價

Single User License$5,950 USD
Enterprise License$6,950 USD
Corporate User License$8,950 USD
洽詢購買 申請 Sample
完整報告名稱與涵蓋範圍
Antibodies Contract Manufacturing Market Size, Share & Trends Analysis Report By Product (Monoclonal Antibodies, Polyclonal Antibodies), By Source (Mammalian, Microbial), By End Use, By Region, And Segment Forecasts, 2026 - 2033

報告摘要

Antibodies Contract Manufacturing Market Summary The global antibodies contract manufacturing market size was valued at USD 19.7 billion in 2025 and is projected to grow from USD 21.5 billion in 2026 to USD 41.0 billion by 2033, at a CAGR of 9.7% from 2026 to 2033. North America dominated the market, accounting for the largest global share of 34.1% in 2025. The growing focus of biopharmaceutical and biotechnology companies on manufacturing antibody therapeutics is a significant factor driving market growth. Market Dynamics The antibodies contract manufacturing market is driven by surging demand for monoclonal antibodies across oncology, autoimmune disorders, and infectious diseases, alongside a robust pipeline of bispecific and next-generation antibody therapeutics. The biopharmaceutical companies outsource production in large numbers to mitigate capital expenditure on bioreactor infrastructure while leveraging CMO expertise in upstream and downstream processing, cell line development, and analytical characterization. In addition, rising approvals of biologics and expanding indications for existing antibody drugs are reinforcing sustained demand for manufacturing. The rising advancements in single-use bioprocessing technologies are enabling faster, more flexible production scale-up for CMOs serving both clinical and commercial-stage clients. However, capacity constraints during peak demand periods, high switching costs, and stringent regulatory compliance requirements pose challenges for new market entrants. Moreover, geopolitical supply chain disruptions and rising raw material costs are prompting manufacturers to diversify production footprints across multiple regions, including emerging Asia Pacific markets. Global Antibodies Contract Manufacturing Market Report Segmentation This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global antibodies contract manufacturing market report based on product, source, end use, and region: • Product Outlook (Revenue, USD Million/Billion, 2021 - 2033) • Monoclonal Antibodies • Polyclonal Antibodies • Others • Source Outlook (Revenue, USD Million/Billion, 2021 - 2033) • Mammalian • Microbial • End Use Outlook (Revenue, USD Million/Billion, 2021 - 2033) • Biopharmaceutical Companies • Research Laboratories • Others • Regional Outlook (Revenue, USD Million/Billion, 2021 - 2033) • North America o U.S. o Canada o Mexico • Europe o UK o Germany o France o Italy o Spain o Denmark o Sweden o Norway • Asia Pacific o Japan o China o India o Australia o Thailand o South Korea • Latin America o Brazil o Argentina • Middle East & Africa o South Africa o UAE o Saudi Arabia o Kuwait o Qatar o Oman
目錄 Table of Contents
Table of Contents Chapter 1. Research Methodology and Scope 1.1. Market Segmentation & Scope 1.2. Segment Definitions 1.2.1. Product 1.2.2. Source 1.2.3. End Use 1.3. Research Methodology 1.4. Information Procurement 1.4.1. Purchased Database 1.4.2. GVR’s Internal Database 1.4.3. Secondary Sources 1.4.4. Primary Research 1.5. Information Or Data Analysis 1.5.1. Data Analysis Models 1.6. Market Formulation & Validation 1.7. Model Details 1.7.1. Commodity Flow Analysis 1.7.2. Top-Down Analysis 1.7.3. Bottom-up Approach 1.7.4. Multivariate Analysis 1.8. List Of Secondary Sources 1.9. List Of Abbreviations 1.10. Objectives Chapter 2. Executive Summary 2.1. Market Outlook 2.2. Segment Outlook 2.3. Competitive Insights Chapter 3. Antibodies Contract Manufacturing Market Variables, Trends & Scope 3.1. Market Lineage Outlook 3.1.1. Parent Market Outlook 3.1.2. Related/Ancillary Market Outlook 3.2. Market Dynamics 3.2.1. Market Driver Analysis 3.2.1.1. Increasing Demand for Monoclonal Antibodies Therapeutics 3.2.1.2. Growing Focus of Biopharmaceutical and Biotechnology Companies 3.2.1.3. Increasing Outsourcing by Biopharmaceutical Companies to Specialized CMOs 3.2.1.4. Expansion of Biologics Clinical Pipelines and Regulatory Approvals 3.2.2. Market Restraint Analysis 3.2.2.1. High Manufacturing Complexity and Production Costs 3.2.2.2. Stringent Regulatory Compliance and Lengthy Validation Processes 3.3. Pricing Model Analysis 3.4. Tariff Impact Analysis 3.5. Value Chain Analysis 3.5.1. Supply Trends 3.5.2. Demand Trends 3.6. Market Analysis Tools 3.6.1. Porter’s Five Force Analysis 3.6.2. PESTEL by SWOT Analysis Chapter 4. Antibodies Contract Manufacturing Market: Product Estimates & Trend Analysis 4.1. Antibodies Contract Manufacturing Market, By Product: Segment Dashboard 4.2. Antibodies Contract Manufacturing Market, By Product: Movement Analysis 4.3. Antibodies Contract Manufacturing Market Estimates & Forecasts, By Product, 2021 - 2033 (USD Million/Billion) 4.4. Monoclonal Antibodies 4.4.1. Monoclonal Antibodies Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) 4.5. Polyclonal Antibodies 4.5.1. Polyclonal Antibodies Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) 4.6. Others 4.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) Chapter 5. Antibodies Contract Manufacturing Market: Source Estimates & Trend Analysis 5.1. Antibodies Contract Manufacturing Market, By Source: Segment Dashboard 5.2. Antibodies Contract Manufacturing Market, By Source: Movement Analysis 5.3. Antibodies Contract Manufacturing Market Estimates & Forecasts, By Source, 2021 - 2033 (USD Million/Billion) 5.4. Mammalian 5.4.1. Mammalian Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) 5.5. Microbial 5.5.1. Microbial Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) Chapter 6. Antibodies Contract Manufacturing Market: End Use Estimates & Trend Analysis 6.1. Antibodies Contract Manufacturing Market, By End Use: Segment Dashboard 6.2. Antibodies Contract Manufacturing Market, By End Use: Movement Analysis 6.3. Antibodies Contract Manufacturing Market Estimates & Forecasts, By End Use, 2021 - 2033 (USD Million/Billion) 6.4. Biopharmaceutical Companies 6.4.1. Biopharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) 6.5. Research Laboratories 6.5.1. Research Laboratories Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) 6.6. Others 6.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) Chapter 7. Antibodies Contract Manufacturing Market: Regional Estimates & Trend Analysis 7.1. Regional Market Dashboard 7.2. Regional Market Share Analysis, 2025 & 2033 7.3. North America 7.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) 7.3.2. U.S 7.3.2.1. Key Country Dynamics 7.3.2.2. Competitive Scenario 7.3.2.3. Regulatory Framework 7.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) 7.3.3. Canada 7.3.3.1. Key Country Dynamics 7.3.3.2. Competitive Scenario 7.3.3.3. Regulatory Framework 7.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) 7.3.4. Mexico 7.3.4.1. Key Country Dynamics 7.3.4.2. Competitive Scenario 7.3.4.3. Regulatory Framework 7.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) 7.4. Europe 7.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) 7.4.2. UK 7.4.2.1. Key Country Dynamics 7.4.2.2. Competitive Scenario 7.4.2.3. Regulatory Framework 7.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) 7.4.3. Germany 7.4.3.1. Key Country Dynamics 7.4.3.2. Competitive Scenario 7.4.3.3. Regulatory Framework 7.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) 7.4.4. France 7.4.4.1. Key Country Dynamics 7.4.4.2. Competitive Scenario 7.4.4.3. Regulatory Framework 7.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) 7.4.5. Italy 7.4.5.1. Key Country Dynamics 7.4.5.2. Competitive Scenario 7.4.5.3. Regulatory Framework 7.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) 7.4.6. Spain 7.4.6.1. Key Country Dynamics 7.4.6.2. Competitive Scenario 7.4.6.3. Regulatory Framework 7.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) 7.4.7. Denmark 7.4.7.1. Key Country Dynamics 7.4.7.2. Competitive Scenario 7.4.7.3. Regulatory Framework 7.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) 7.4.8. Sweden 7.4.8.1. Key Country Dynamics 7.4.8.2. Competitive Scenario 7.4.8.3. Regulatory Framework 7.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) 7.4.9. Norway 7.4.9.1. Key Country Dynamics 7.4.9.2. Competitive Scenario 7.4.9.3. Regulatory Framework 7.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) 7.5. Asia Pacific 7.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) 7.5.2. Japan 7.5.2.1. Key Country Dynamics 7.5.2.2. Competitive Scenario 7.5.2.3. Regulatory Framework 7.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) 7.5.3. China 7.5.3.1. Key Country Dynamics 7.5.3.2. Competitive Scenario 7.5.3.3. Regulatory Framework 7.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) 7.5.4. India 7.5.4.1. Key Country Dynamics 7.5.4.2. Competitive Scenario 7.5.4.3. Regulatory Framework 7.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) 7.5.5. Australia 7.5.5.1. Key Country Dynamics 7.5.5.2. Competitive Scenario 7.5.5.3. Regulatory Framework 7.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) 7.5.6. Thailand 7.5.6.1. Key Country Dynamics 7.5.6.2. Competitive Scenario 7.5.6.3. Regulatory Framework 7.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) 7.5.7. South Korea 7.5.7.1. Key Country Dynamics 7.5.7.2. Competitive Scenario 7.5.7.3. Regulatory Framework 7.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) 7.6. Latin America 7.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) 7.6.2. Brazil 7.6.2.1. Key Country Dynamics 7.6.2.2. Competitive Scenario 7.6.2.3. Regulatory Framework 7.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) 7.6.3. Argentina 7.6.3.1. Key Country Dynamics 7.6.3.2. Competitive Scenario 7.6.3.3. Regulatory Framework 7.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) 7.7. MEA 7.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) 7.7.2. South Africa 7.7.2.1. Key Country Dynamics 7.7.2.2. Competitive Scenario 7.7.2.3. Regulatory Framework 7.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) 7.7.3. UAE 7.7.3.1. Key Country Dynamics 7.7.3.2. Competitive Scenario 7.7.3.3. Regulatory Framework 7.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) 7.7.4. Saudi Arabia 7.7.4.1. Key Country Dynamics 7.7.4.2. Competitive Scenario 7.7.4.3. Regulatory Framework 7.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) 7.7.5. Kuwait 7.7.5.1. Key Country Dynamics 7.7.5.2. Competitive Scenario 7.7.5.3. Regulatory Framework 7.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) 7.7.6. Qatar 7.7.6.1. Key Country Dynamics 7.7.6.2. Competitive Scenario 7.7.6.3. Regulatory Framework 7.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) 7.7.7. Oman 7.7.7.1. Key Country Dynamics 7.7.7.2. Competitive Scenario 7.7.7.3. Regulatory Framework 7.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) Chapter 8. Competitive Landscape 8.1. Key Participant Categorization 8.1.1. Market Leaders 8.1.2. Emerging Players 8.2. Market Assessment Analysis, 2025 (Heat Map Analysis) 8.3. Company Profiles 8.3.1. Lonza 8.3.1.1. Company Overview 8.3.1.2. Financial Performance 8.3.1.3. Service Benchmarking 8.3.1.4. Strategic Initiatives 8.3.2. Samsung Biologics 8.3.2.1. Company Overview 8.3.2.2. Financial Performance 8.3.2.3. Service Benchmarking 8.3.2.4. Strategic Initiatives 8.3.3. WuXi Biologics 8.3.3.1. Company Overview 8.3.3.2. Financial Performance 8.3.3.3. Service Benchmarking 8.3.3.4. Strategic Initiatives 8.3.4. Charles River Laboratories 8.3.4.1. Company Overview 8.3.4.2. Financial Performance 8.3.4.3. Service Benchmarking 8.3.4.4. Strategic Initiatives 8.3.5. FUJIFILM Holdings Corporation 8.3.5.1. Company Overview 8.3.5.2. Financial Performance 8.3.5.3. Service Benchmarking 8.3.5.4. Strategic Initiatives 8.3.6. Boehringer Ingelheim Biopharmaceuticals GmbH 8.3.6.1. Company Overview 8.3.6.2. Financial Performance 8.3.6.3. Service Benchmarking 8.3.6.4. Strategic Initiatives 8.3.7. AGC Biologics 8.3.7.1. Company Overview 8.3.7.2. Financial Performance 8.3.7.3. Service Benchmarking 8.3.7.4. Strategic Initiatives 8.3.8. Cytovance Biologics, Inc. 8.3.8.1. Company Overview 8.3.8.2. Financial Performance 8.3.8.3. Service Benchmarking 8.3.8.4. Strategic Initiatives 8.3.9. EMERGENT 8.3.9.1. Company Overview 8.3.9.2. Financial Performance 8.3.9.3. Service Benchmarking 8.3.9.4. Strategic Initiatives 8.3.10. Thermo Fisher Scientific 8.3.10.1. Company Overview 8.3.10.2. Financial Performance 8.3.10.3. Service Benchmarking 8.3.10.4. Strategic Initiatives 8.3.11. Labcorp Drug Development 8.3.11.1. Company Overview 8.3.11.2. Financial Performance 8.3.11.3. Service Benchmarking 8.3.11.4. Strategic Initiatives 8.3.12. Catalent, Inc. 8.3.12.1. Company Overview 8.3.12.2. Financial Performance 8.3.12.3. Service Benchmarking 8.3.12.4. Strategic Initiatives
圖表清單 List of Tables & Figures
List of Tables Table 1 List of Secondary Sources Table 2 List of Abbreviations Table 3 North America Antibodies Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million/Billion) Table 4 North America Antibodies Contract Manufacturing Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million/Billion) Table 5 North America Antibodies Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million/Billion) Table 6 North America Antibodies Contract Manufacturing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million/Billion) Table 7 U.S. Antibodies Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million/Billion) Table 8 U.S. Antibodies Contract Manufacturing Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million/Billion) Table 9 U.S. Antibodies Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million/Billion) Table 10 Canada Antibodies Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million/Billion) Table 11 Canada Antibodies Contract Manufacturing Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million/Billion) Table 12 Canada Antibodies Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million/Billion) Table 13 Mexico Antibodies Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million/Billion) Table 14 Mexico Antibodies Contract Manufacturing Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million/Billion) Table 15 Mexico Antibodies Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million/Billion) Table 16 Europe Antibodies Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million/Billion) Table 17 Europe Antibodies Contract Manufacturing Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million/Billion) Table 18 Europe Antibodies Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million/Billion) Table 19 Europe Antibodies Contract Manufacturing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million/Billion) Table 20 UK Antibodies Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million/Billion) Table 21 UK Antibodies Contract Manufacturing Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million/Billion) Table 22 UK Antibodies Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million/Billion) Table 23 Germany Antibodies Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million/Billion) Table 24 Germany Antibodies Contract Manufacturing Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million/Billion) Table 25 Germany Antibodies Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million/Billion) Table 26 France Antibodies Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million/Billion) Table 27 France Antibodies Contract Manufacturing Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million/Billion) Table 28 France Antibodies Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million/Billion) Table 29 Spain Antibodies Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million/Billion) Table 30 Spain Antibodies Contract Manufacturing Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million/Billion) Table 31 Spain Antibodies Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million/Billion) Table 32 Italy Antibodies Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million/Billion) Table 33 Italy Antibodies Contract Manufacturing Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million/Billion) Table 34 Italy Antibodies Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million/Billion) Table 35 Sweden Antibodies Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million/Billion) Table 36 Sweden Antibodies Contract Manufacturing Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million/Billion) Table 37 Sweden Antibodies Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million/Billion) Table 38 Norway Antibodies Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million/Billion) Table 39 Norway Antibodies Contract Manufacturing Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million/Billion) Table 40 Norway Antibodies Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million/Billion) Table 41 Denmark Antibodies Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million/Billion) Table 42 Denmark Antibodies Contract Manufacturing Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million/Billion) Table 43 Denmark Antibodies Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million/Billion) Table 44 Asia Pacific Antibodies Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million/Billion) Table 45 Asia Pacific Antibodies Contract Manufacturing Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million/Billion) Table 46 Asia Pacific Antibodies Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million/Billion) Table 47 Asia Pacific Antibodies Contract Manufacturing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million/Billion) Table 48 Japan Antibodies Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million/Billion) Table 49 Japan Antibodies Contract Manufacturing Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million/Billion) Table 50 Japan Antibodies Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million/Billion) Table 51 China Antibodies Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million/Billion) Table 52 China Antibodies Contract Manufacturing Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million/Billion) Table 53 China Antibodies Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million/Billion) Table 54 India Antibodies Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million/Billion) Table 55 India Antibodies Contract Manufacturing Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million/Billion) Table 56 India Antibodies Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million/Billion) Table 57 Australia Antibodies Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million/Billion) Table 58 Australia Antibodies Contract Manufacturing Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million/Billion) Table 59 Australia Antibodies Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million/Billion) Table 60 Thailand Antibodies Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million/Billion) Table 61 Thailand Antibodies Contract Manufacturing Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million/Billion) Table 62 Thailand Antibodies Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million/Billion) Table 63 South Korea Antibodies Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million/Billion) Table 64 South Korea Antibodies Contract Manufacturing Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million/Billion) Table 65 South Korea Antibodies Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million/Billion) Table 66 Latin America Antibodies Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million/Billion) Table 67 Latin America Antibodies Contract Manufacturing Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million/Billion) Table 68 Latin America Antibodies Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million/Billion) Table 69 Latin America Antibodies Contract Manufacturing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million/Billion) Table 70 Brazil Antibodies Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million/Billion) Table 71 Brazil Antibodies Contract Manufacturing Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million/Billion) Table 72 Brazil Antibodies Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million/Billion) Table 73 Argentina Antibodies Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million/Billion) Table 74 Argentina Antibodies Contract Manufacturing Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million/Billion) Table 75 Argentina Antibodies Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million/Billion) Table 76 MEA Antibodies Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million/Billion) Table 77 MEA Antibodies Contract Manufacturing Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million/Billion) Table 78 MEA Antibodies Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million/Billion) Table 79 MEA Antibodies Contract Manufacturing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million/Billion) Table 80 South Africa Antibodies Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million/Billion) Table 81 South Africa Antibodies Contract Manufacturing Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million/Billion) Table 82 South Africa Antibodies Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million/Billion) Table 83 Saudi Arabia Antibodies Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million/Billion) Table 84 Saudi Arabia Antibodies Contract Manufacturing Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million/Billion) Table 85 Saudi Arabia Antibodies Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million/Billion) Table 86 UAE Antibodies Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million/Billion) Table 87 UAE Antibodies Contract Manufacturing Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million/Billion) Table 88 UAE Antibodies Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million/Billion) Table 89 Kuwait Antibodies Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million/Billion) Table 90 Kuwait Antibodies Contract Manufacturing Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million/Billion) Table 91 Kuwait Antibodies Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million/Billion) Table 92 Oman Antibodies Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million/Billion) Table 93 Oman Antibodies Contract Manufacturing Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million/Billion) Table 94 Oman Antibodies Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million/Billion) Table 95 Qatar Antibodies Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million/Billion) Table 96 Qatar Antibodies Contract Manufacturing Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million/Billion) Table 97 Qatar Antibodies Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million/Billion) List of Figures Fig. 1 Market research process Fig. 2 Information procurement Fig. 3 Primary research pattern Fig. 4 Market research approaches Fig. 5 Market formulation & validation Fig. 6 Commodity flow analysis Fig. 7 Value-chain-based sizing & forecasting Fig. 8 QFD model sizing & forecasting Fig. 9 Bottom-up approach Fig. 10 Market snapshot Fig. 11 Segment snapshot 1 Fig. 12 Segment snapshot 2 Fig. 13 Competitive landscape snapshot Fig. 14 Parent market outlook, 2025 (USD Billion) Fig. 15 Ancillary market outlook, 2025 (USD Billion) Fig. 16 Large Molecule Drug Substance Market Dynamics Fig. 17 Porter’s five forces analysis Fig. 18 PESTEL analysis Fig. 19 Antibodies Contract Manufacturing Market Product Outlook: Segment Dashboard Fig. 20 Antibodies Contract Manufacturing Market, by Product Segment: Market Share, 2025 & 2033 Fig. 21 Monoclonal Antibodies Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) Fig. 22 Polyclonal Antibodies Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) Fig. 23 Others Market Estimates and forecasts, 2021 - 2033 (USD Million/Billion) Fig. 24 Antibodies Contract Manufacturing Market Source outlook: Segment dashboard Fig. 25 Antibodies Contract Manufacturing Market, by Source Segment: Market Share, 2025 & 2033 Fig. 26 Mammalian Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) Fig. 27 Microbial Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) Fig. 28 Antibodies Contract Manufacturing Market End Use outlook: Segment dashboard Fig. 29 Antibodies Contract Manufacturing Market, by End Use Segment: Market Share, 2025 & 2033 Fig. 30 Biopharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) Fig. 31 Research Laboratories Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) Fig. 32 Others Market Estimates and forecasts, 2021 - 2033 (USD Million/Billion) Fig. 33 Regional Marketplace: Key Takeaways Fig. 34 North America Antibodies Contract Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million/Billion) Fig. 35 Key country dynamics Fig. 36 U.S. Antibodies Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) Fig. 37 Key country dynamics Fig. 38 Canada Antibodies Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) Fig. 39 Key country dynamics Fig. 40 Mexico Antibodies Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) Fig. 41 Europe Antibodies Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) Fig. 42 Key country dynamics Fig. 43 UK Antibodies Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) Fig. 44 Key country dynamics Fig. 45 Germany Antibodies Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) Fig. 46 Key country dynamics Fig. 47 France Antibodies Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) Fig. 48 Key country dynamics Fig. 49 Italy Antibodies Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) Fig. 50 Key country dynamics Fig. 51 Spain Antibodies Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) Fig. 52 Key country dynamics Fig. 53 Denmark Antibodies Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) Fig. 54 Key country dynamics Fig. 55 Sweden Antibodies Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) Fig. 56 Key country dynamics Fig. 57 Norway Antibodies Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) Fig. 58 Asia Pacific Antibodies Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) Fig. 59 Key country dynamics Fig. 60 Japan Antibodies Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) Fig. 61 Key country dynamics Fig. 62 China Antibodies Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) Fig. 63 Key country dynamics Fig. 64 India Antibodies Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) Fig. 65 Key country dynamics Fig. 66 Australia Antibodies Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) Fig. 67 Key country dynamics Fig. 68 Thailand Antibodies Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) Fig. 69 Key country dynamics Fig. 70 South Korea Antibodies Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) Fig. 71 Latin America Antibodies Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) Fig. 72 Key country dynamics Fig. 73 Brazil Antibodies Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) Fig. 74 Key country dynamics Fig. 75 Argentina Antibodies Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) Fig. 76 MEA Antibodies Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) Fig. 77 Key country dynamics Fig. 78 South Africa Antibodies Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) Fig. 79 Key country dynamics Fig. 80 UAE Antibodies Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) Fig. 81 Key country dynamics Fig. 82 Saudi Arabia Antibodies Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) Fig. 83 Key country dynamics Fig. 84 Kuwait Antibodies Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) Fig. 85 Key country dynamics Fig. 86 Qatar Antibodies Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion) Fig. 87 Key country dynamics Fig. 88 Oman Antibodies Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)

提及公司

LonzaSamsung BiologicsWuXi Biologics.Charles River LaboratoriesFUJIFILM Holdings CorporationBoehringer Ingelheim Biopharmaceuticals GmbHAGC BiologicsCytovance Biologics, Inc.EMERGENTThermo Fisher ScientificLabcorp Drug DevelopmentCatalent, Inc.

同分類最新報告（醫療器材）

查看醫療器材全部報告 →

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Grand View Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們